| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000868A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | WO2003000867A1 Yeast transformation vector containing auxotrophic dominant gene, yeast transformant containing it and their preparation |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000863A2 Defensin polynucleotides and methods of use |
| 01/03/2003 | WO2003000862A2 Homeotic genes and proteins, and uses thereof |
| 01/03/2003 | WO2003000861A2 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000854A2 Double fructan beets |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000847A2 Membrane associated progesterone receptor |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000840A2 Nitrilases |
| 01/03/2003 | WO2003000776A1 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/03/2003 | WO2003000737A2 MOUSE μ LIGHT CHAIN LOCUS |
| 01/03/2003 | WO2003000735A2 Nucleic acids encoding olfactory receptors |
| 01/03/2003 | WO2003000732A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 01/03/2003 | WO2003000730A1 Compounds that modulate estrogen actions |
| 01/03/2003 | WO2003000729A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 01/03/2003 | WO2003000728A2 Testis protein, zsig86 |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000724A2 Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders |
| 01/03/2003 | WO2003000723A1 Transport proteins for nitrogenous heterocycles and nucleic acids encoding them |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000719A2 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 01/03/2003 | WO2003000718A2 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000715A1 Chimeric histone acetyltransferase polypeptides |
| 01/03/2003 | WO2003000707A2 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000405A2 Biochips comprising nucleic acid/protein conjugates |
| 01/03/2003 | WO2003000297A1 Method of promoting nucleic acid transfer |
| 01/03/2003 | WO2003000296A2 Treatment and diagnostic of b cell chronic lymphocytic leukaemia |
| 01/03/2003 | WO2003000291A1 Lipid vesicles, process for producing lipid vesicles and method of immobilizing gene on lipid vesicles |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | WO2003000280A2 Abin-mediated hepatitis protection |
| 01/03/2003 | WO2003000273A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | WO2003000174A2 Compositions and methods for intracellular delivery |
| 01/03/2003 | WO2003000114A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2003000046A1 Cyt28 serpentine receptor disruptions, compositions and methods relating thereto |
| 01/03/2003 | WO2003000041A1 Method of constructing transgenic plant with improved amino acid composition and yield |
| 01/03/2003 | WO2003000038A2 Compositions and methods for modulating plant development |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000009A2 Stimulation of vascularization with vegf-b |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002081661A3 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002060939A3 Method for increasing the sulphur-compound content in plants |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002057467A3 Use of umbravirus in protection against post-transcriptional gene silencing |
| 01/03/2003 | WO2002055725A9 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 01/03/2003 | WO2002052923A3 Long day plants transformed with phytochrome characterized by altered flowering response to day length |
| 01/03/2003 | WO2002051856A3 Method for immobilising probes, in particular for producing biochips |
| 01/03/2003 | WO2002050248A3 Antisense modulation of hepsin expression |
| 01/03/2003 | WO2002046430A3 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 01/03/2003 | WO2002046377A3 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002044322A3 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 01/03/2003 | WO2002044202A3 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 01/03/2003 | WO2002043647A3 Oncolytic virus |
| 01/03/2003 | WO2002042449A3 Method for selecting peptide ligands |
| 01/03/2003 | WO2002031149A3 Polyvalent cation-sensing receptor proteins in aquatic species |
| 01/03/2003 | WO2002030966A3 Alzheimer's disease-associated proteins |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002026757A3 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020764A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020612A3 Human vomeronasal receptor-3 |
| 01/03/2003 | WO2002020562A3 Family member of inhibitor of apoptosis proteins |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002016609A3 Self-excising polynucleotides and uses thereof |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002012518A3 Floral induction gene |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012500A3 Anti-il-12 antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012471A3 Angiotensin converting enzyme homolog and uses therefor |
| 01/03/2003 | WO2002012330A3 Human secreted protein, zzp1 |
| 01/03/2003 | WO2002012329A3 Compositions and methods for the therapy and diagnosis of head and neck cancer |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002010386A3 Human vomeronasal receptor |
| 01/03/2003 | WO2002008402A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 01/03/2003 | WO2002008264A3 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/03/2003 | WO2002006468A3 METHYL CpG BINDING DOMAIN NUCLEIC ACIDS FROM MAIZE |
| 01/03/2003 | WO2002004653A3 Sinapoylglucose : malate sinapoyltransferase forms malate conjugates from benozic acid glucosides |
| 01/03/2003 | WO2002004650A3 Methods for maximizing expression of transgenic traits in autopolyploid plants |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002002788A3 Methods for helper-dependent adenoviral vector production |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002627A3 Interferon-like protein zcyto21 |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000856A3 Protein glycosylation modification in pichia pastoris |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |